ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Net margin 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) net profit margin by fiscal year — reported net income divided by reported revenue.
-0.2%FY2025 · since FY2016: -51614.6% → -0.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.2% | +16882.2 pp |
| FY2024 | -16882.4% | -16797.1 pp |
| FY2023 | -85.3% | -12.9 pp |
| FY2022 | -72.4% | +29.5 pp |
| FY2021 | -101.9% | -5.8 pp |
| FY2020 | -96.1% | -136.4 pp |
| FY2019 | 40.3% | +377.6 pp |
| FY2018 | -337.3% | -227.9 pp |
| FY2017 | -109.5% | +51505.2 pp |
| FY2016 | -51614.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice